ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification.

A Laroni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.